Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.35 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Miconazole is a widely used antifungal agent with poor aqueous solubility, which requires the
development of drug delivery systems able to improve its therapeutic activity. For this purpose, a
miconazole-loaded nanostructured lipid carriers (NLC) dispersion was prepared and characterized. Further, the dispersion was used to prepare a NLC-based hydrogel formulation proposed as an alternative
system to improve the local delivery of miconazole to the oral mucosa. NLC dispersion showed particles in the nanometer range (≈200 nm) with low polidispersity index (<0.3), good physical stability and
high encapsulation efficiency (>87%). A controlled miconazole release was observed from NLC and NLCbased hydrogel formulations, in contrast to a commercial oral gel formulation, which demonstrated a
faster release. Additionally, it was observed that the encapsulation of miconazole in the NLC improved
its antifungal activity against Candida albicans. Therefore, it was demonstrated that the encapsulation of
miconazole in NLC allows for obtaining the same therapeutic effect of a commercial oral gel formulation,
using a 17-fold lower dose of miconazole.
Description
Keywords
Miconazole Nanostructured lipid carriers Oral mucosa Hydrogel Controlled release Antifungal activity
Citation
Publisher
Elsevier